Paclitaxel DCB
Sponsors
Beijing Hospital, Peking University Third Hospital, University Hospital, Essen, Cook Research Incorporated
Conditions
Coronary Artery DiseaseCoronary DiseaseDrug Eluting BalloonFlow-mediated DilationInfrainguinal Peripheral Arterial DiseasePeripheral Arterial DiseasePeripheral Vascular Disease
Unknown Phase
Clinical Trial on Safety and Efficacy of Drug-coated Balloon in Treatment of Coronary Bifurcation Lesions
CompletedNCT03223974
Start: 2017-11-16End: 2021-02-28Updated: 2022-03-22
Angioplasty With Paclitaxel-coated Balloon Only Strategy for Coronary de Novo Lesions
NCT04022200
Start: 2019-08-01End: 2023-07-31Target: 300Updated: 2022-03-22
Comparative Clinical Study of Drug-coating Balloon Strategy and Drug-eluting Stent Strategy
NCT04842838
Start: 2021-06-30End: 2025-06-30Target: 1000Updated: 2021-04-13
Vascular Effects Through Sirolimus vs. Paclitaxel DCB Implantation
NCT05450042
Start: 2022-04-06End: 2024-04-06Target: 70Updated: 2023-12-05
EVERO Drug-coated Balloon (DCB) Randomized Trial
RecruitingNCT07144150
Start: 2026-05-01End: 2032-10-01Target: 410Updated: 2026-04-06